CINECA IRIS Institutional Research Information System

RICCI, GIULIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.329
EU - Europa 1.978
AS - Asia 1.742
AF - Africa 220
SA - Sud America 214
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 2
Totale 12.490
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.924
CA - Canada 2.397
CN - Cina 680
SG - Singapore 596
IT - Italia 587
DE - Germania 341
SE - Svezia 295
HK - Hong Kong 249
BG - Bulgaria 221
BR - Brasile 201
CI - Costa d'Avorio 162
RU - Federazione Russa 141
GB - Regno Unito 126
VN - Vietnam 102
FI - Finlandia 63
TR - Turchia 55
AT - Austria 44
FR - Francia 33
UA - Ucraina 29
IN - India 23
NG - Nigeria 23
SN - Senegal 23
BE - Belgio 16
NL - Olanda 15
ES - Italia 10
CH - Svizzera 9
IE - Irlanda 9
CZ - Repubblica Ceca 8
GR - Grecia 7
AR - Argentina 4
AU - Australia 4
DK - Danimarca 4
EC - Ecuador 4
HU - Ungheria 4
IQ - Iraq 4
IR - Iran 4
LT - Lituania 4
PH - Filippine 4
ZA - Sudafrica 4
BD - Bangladesh 3
HR - Croazia 3
ID - Indonesia 3
IL - Israele 3
MA - Marocco 3
MX - Messico 3
AM - Armenia 2
AZ - Azerbaigian 2
DO - Repubblica Dominicana 2
EU - Europa 2
JP - Giappone 2
NI - Nicaragua 2
NO - Norvegia 2
PE - Perù 2
PL - Polonia 2
PT - Portogallo 2
SA - Arabia Saudita 2
TN - Tunisia 2
BJ - Benin 1
CO - Colombia 1
EE - Estonia 1
EG - Egitto 1
JO - Giordania 1
KG - Kirghizistan 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
MY - Malesia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
RO - Romania 1
RS - Serbia 1
TG - Togo 1
TH - Thailandia 1
UY - Uruguay 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 12.490
Salva come PNG Salva come JPEG
Città #
Montreal 2.303
Woodbridge 625
Fairfield 605
Houston 559
Santa Clara 545
Ashburn 519
Ann Arbor 497
Chandler 423
Seattle 309
Singapore 297
Shanghai 283
Hong Kong 243
Wilmington 241
Sofia 221
Cambridge 204
Abidjan 162
Beijing 155
New York 141
Serra 125
Boardman 118
Princeton 113
Lawrence 97
Medford 85
Ottawa 80
Milan 64
Florence 62
Des Moines 49
Ogden 39
Vienna 39
Jacksonville 38
Rome 36
Dong Ket 34
Nanjing 34
Istanbul 32
San Diego 32
Lancaster 27
London 24
Pisa 24
Dakar 23
Lagos 23
Bremen 22
Frankfurt am Main 22
Hebei 18
Izmir 18
Munich 18
Redwood City 18
Shenyang 18
Nanchang 17
Dearborn 16
Düsseldorf 16
Brussels 15
Helsinki 15
Los Angeles 15
Fuzhou 14
Jiaxing 14
Nuremberg 14
Norwalk 13
Genoa 12
Kunming 12
Nürnberg 12
São Paulo 12
Jüchen 11
Council Bluffs 10
Dublin 8
Kent 8
Rio de Janeiro 8
Toronto 8
Tulsa 8
Cascina 7
Belo Horizonte 6
Bern 6
Boulder 6
Changsha 6
Curitiba 6
Dallas 6
Guangzhou 6
Hefei 6
Jinan 6
Lucca 6
Madrid 6
Naples 6
Pune 6
Nittenau 5
Padova 5
Quanzhou 5
Salvador 5
San Francisco 5
Wuhan 5
Alessandria 4
Budapest 4
Enterprise 4
Kostroma 4
Phoenix 4
Prague 4
Saint-palais-sur-mer 4
The Dalles 4
Caloocan City 3
Campinas 3
Central District 3
Chengdu 3
Totale 10.081
Salva come PNG Salva come JPEG
Nome #
A Clinical Tool for Prognosis and Speech Rehabilitation in Dysarthric Patients: The DESIRE Project 2.382
Serum gamma-glutamyltransferase fractions in myotonic dystrophy type I: differences with healthy subjects and patients with liver disease 241
A novel clinical tool to classify facioscapulohumeral muscular dystrophy phenotypes 232
Metabolic myopathies: functional evaluation by different exercise testing approaches 207
Autosomal dominant psychiatric disorders and mitochondrial DNA multiple deletions: report of a family 204
Inflammatory myopathy in a patient with postural and kinetik tremor. 174
Oxidative stress treatment for clinical trials in neurodegenerative diseases. 171
Nerve, muscle and heart acute toxicity following oxaliplatin and capecitabine treatment. 165
Astrocyte-neuron interactions in neurological disorders 164
Mitochondria and neurodegeneration 161
Lack of association between mtDNA haplogroups and Alzheimer's disease in Tuscany 161
Pes cavus and hereditary neuropathies: when a relationship should be suspected. 156
Effects of aerobic training on exercise-related oxidative stress in mitochondrial myopathies. 150
New motor outcome function measures in evaluation of late-onset Pompe disease before and after enzyme replacement therapy. 147
LOPED study: Looking for an early diagnosis in a late-onset Pompe disease high-risk population 145
Congenital myopathies: Clinical phenotypes and new diagnostic tools 142
A wearable pervasive platform for intelligent monitoring of muscular fatigue 141
Multidisciplinary study of a new ClC-1 mutation causing myotonia congenita: a paradigm to understand and treat ion channelopathies 141
Study of the porcine dermal collagen repair patch in morpho-functional recovery of the rotator cuff after minimum follow-up of 2.5 years 141
NMR voxel-based morphometry and functional analysis as neural correlates of neuropsychological dysfunction in DM1 141
Cross-talk between pathogenic mechanisms in neurodegeneration: the role of oxidative stress in Amyotrophic Lateral Sclerosis 140
LMNA-associated myopathies: the Italian experience in a large cohort of patients 137
Folate, homocysteine, vitamin B12 and polymorphisms of genes participating in one-carbon metabolism in late onset Alzheimer's disease patients and healthy controls. 136
Next-generation sequencing identifies transportin 3 as the causative gene for LGMD1F. 134
A personal monitoring architecture to detect muscular fatigue in elderly. 133
ClC-1 mutations in myotonia congenita patients: Insights into molecular gating mechanisms and genotype-phenotype correlation 133
Clinical expression of facioscapulohumeral muscular dystrophy in carriers of 1-3 D4Z4 reduced alleles: experience of the FSHD Italian National Registry 127
Prevalent cardiac phenotype resulting in heart transplantation in a novel LMNA gene duplication 127
Broad phenotypic spectrum and genotype-phenotype correlations in GMPPB-related dystroglycanopathies: an Italian cross-sectional study 126
Observational clinical study in juvenile-adult glycogenosis type 2 patients undergoing enzyme replacement therapy for up to 4 years. 124
A pervasive activity management and rehabilitation support system for the elderly 122
Large-scale population analysis challenges the current criteria for the molecular diagnosis of fascioscapulohumeral muscular dystrophy. 119
A mobile app for patients with Pompe disease and its possible clinical applications 116
Large scale genotype-phenotype analyses indicate that novel prognostic tools are required for families with facioscapulohumeral muscular dystrophy. 115
CMR-verified interstitial myocardial fibrosis as a marker of subclinical cardiac involvement in LMNA mutation carriers. 114
Large scale genotype-phenotype analyses indicate that novel prognostic tools are required for families with facioscapulohumeral muscular dystrophy. 113
Rippling muscle disease and facioscapulohumeral dystrophy-like phenotype in a patient carrying a heterozygous CAV3 T78M mutation and a D4Z4 partial deletion: Further evidence for "double trouble" overlapping syndromes 109
The empowerment of translational research: lessons from laminopathies 109
Identification and characterization of three novel mutations in the CASQ1 gene in four patients with tubular aggregate myopathy 108
An Ontology-driven Multisensorial Platform to Enable Unobtrusive Human Monitoring and Independent Living 106
"I have got something positive out of this situation": Psychological benefits of caregiving in relatives of young people with muscular dystrophy 105
Physical exercise and oxidative stress in muscular dystrophies: is there a good balance? Exercise and oxidative stress in MDs 101
Genetic characterization in symptomatic female DMD carriers: lack of relationship between X-inactivation, transcriptional DMD allele balancing and phenotype 101
The genetic basis of undiagnosed muscular dystrophies and myopathies: Results from 504 patients 101
Assessing the Role of Anti rh-GAA in Modulating Response to ERT in a Late-Onset Pompe Disease Cohort from the Italian GSDII Study Group. 97
A novel family with axonal Charcot-Marie-Tooth disease caused by a mutation in the EGR2 gene 96
D4Z4 reduced allele in myopathic subjects with no FSHD phenotype: why inconsistency between molecular and clinical data should prompt us to further investigations. 94
A multi-parametric protocol to study exercise intolerance in McArdle's disease 92
Facioscapulohumeral muscular dystrophy: New insights from compound heterozygotes and implication for prenatal genetic counselling 92
Elevated TGF β2 serum levels in Emery-Dreifuss Muscular Dystrophy: Implications for myocyte and tenocyte differentiation and fibrogenic processes 92
The proposal of a clinical protocol to assess central and peripheral fatigue in myotonic dystrophy type 1 91
The italian limb girdle muscular dystrophy registry: Relative frequency, clinical features, and differential diagnosis 91
Hard ways towards adulthood: the transition phase in young people with myotonic dystrophy 88
null 88
Tubular Aggregates Myopathy: case description 86
FUNCTIONAL DIAGNOSTICS IN MITOCHINDRIAL DISEASES 84
Facioscapulohumeral muscular dystrophy: more complex than it appears 83
A mutation in the CASQ1 gene causes a vacuolar myopathy with accumulation of sarcoplasmic reticulum protein aggregates 82
null 81
Exercise-Related Oxidative Stress as Mechanism to Fight Physical Dysfunction in Neuromuscular Disorders 78
Exercise therapy in muscle diseases: open issues and future perspectives 76
Clinical and Molecular Spectrum of Myotonia and Periodic Paralyses Associated With Mutations in SCN4A in a Large Cohort of Italian Patients 75
Novel LMNA gene mutation in a patient with cardiac and skeletal muscle involvement 74
Chronic inflammatory demyelinating polyneuropathy associated with multiple sclerosis 74
Cardiac magnetic resonance in patients with muscular dystrophies 74
Posterior reversible encephalopathy syndrome in a complicated autoimmune background: Differential diagnosis and etiological hypothesis 73
Cardiac and neuromuscular features of patients with LMNA-related cardiomyopathy 73
A case of intravascular large B cell lymphoma with brain involvement mimicking progressive multifocal leukoencephalopathy 70
A Single mtDNA Deletion in Association with a LMNA Gene New Frameshift Variant: A Case Report 69
Nusinersen treatment and cerebrospinal fluid neurofilaments: An explorative study on Spinal Muscular Atrophy type 3 patients 66
Central Nervous System Involvement as Outcome Measure for Clinical Trials Efficacy in Myotonic Dystrophy Type 1 65
Disease awareness in myotonic dystrophy type 1: an observational cross-sectional study 64
Psychosocial impact of sport activity in neuromuscular disorders 62
A 5-year clinical follow-up study from the Italian National Registry for FSHD 62
Response. 61
Phenotype may predict the clinical course of facioscapolohumeral muscular dystrophy 59
A multicenter retrospective study of charcot-marie-tooth disease type 4B (CMT4B) associated with mutations in myotubularin-related proteins (MTMRs) 59
Cytokine Profile in Striated Muscle Laminopathies: New Promising Biomarkers for Disease Prediction 59
Mitochondrial DNA transcription and translation: Clinical syndromes 56
Mutations in glycyl-tRNA synthetase impair mitochondrial metabolism in neurons 55
Frailties and critical issues in neuromuscular diseases highlighted by SARS-CoV-2 pandemic: how many patients are still "invisible"? 55
Fatigue as a common signature of inflammatory myopathies: clinical aspects and care 54
null 53
Expanding the clinical and genetic spectrum of pathogenic variants in STIM1 53
Phenotypic Variability Among Patients With D4Z4 Reduced Allele Facioscapulohumeral Muscular Dystrophy 50
Neural aspects in simultaneous interpreting: The role of music in intralingual and interlingual activities 50
Muscle exercise in limb girdle muscular dystrophies: pitfall and advantages 49
Interpretation of the epigenetic signature of facioscapulohumeral muscular dystrophy in light of genotype-phenotype studies 48
Integrated care of muscular dystrophies in Italy. Part 2. Psychological treatments, social and welfare support, and financial costs 48
Management of motor rehabilitation in individuals with muscular dystrophies. 1st Consensus Conference report from UILDM - Italian Muscular Dystrophy Association (Rome, January 25-26, 2019) 48
Pathophysiology and Management of Fatigue in Neuromuscular Diseases 47
Functional diagnostics in mitochondrial diseases 47
Next-generation sequencing application to investigate skeletal muscle channelopathies in a large cohort of Italian patients 47
Anti-HMGCR antibodies and asymptomatic hyperCKemia. A case report 47
Primary mitochondrial myopathy: 12-month follow-up results of an Italian cohort 46
The genetic landscape of axonal neuropathies in the middle-aged and elderly: Focus on MME 45
Diagnostic and prognostic value of CSF neurofilaments in a cohort of patients with motor neuron disease: A cross-sectional study 43
Estimating the impact of COVID-19 pandemic on services provided by Italian Neuromuscular Centers: an Italian Association of Myology survey of the acute phase 42
Characterization of Phenotypic Variability in Becker Muscular Dystrophy for Clinical Practice and Towards Trial Readiness: A Two-Years Follow up Study 40
Large genotype–phenotype study in carriers of D4Z4 borderline alleles provides guidance for facioscapulohumeral muscular dystrophy diagnosis 40
Totale 12.115
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.534
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.534
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020289 0 0 0 0 0 0 0 0 0 130 128 31
2020/2021718 49 44 30 36 47 71 70 45 88 49 39 150
2021/2022983 21 48 23 69 161 129 27 51 45 41 73 295
2022/20231.390 151 175 87 104 149 149 10 100 320 8 109 28
2023/20243.170 46 75 85 32 121 132 98 39 26 2.333 63 120
2024/20252.587 13 125 84 193 398 408 344 205 352 465 0 0
Totale 12.663